Corporate ActionMay 14, 2026, 05:07 PM
MAIA Biotechnology Terminates ATM Offering Agreement
AI Summary
MAIA Biotechnology, Inc. has terminated its At The Market Offering Agreement with H.C. Wainwright & Co., LLC, effective 7 business days after May 14, 2026. Since March 28, 2025, the company sold 3,116,012 shares of common stock under this agreement, generating gross proceeds of approximately $5,680,924.
Key Highlights
- MAIA Biotechnology terminated its At The Market Offering Agreement.
- The agreement was with H.C. Wainwright & Co., LLC.
- Termination is effective 7 business days after May 14, 2026.
- The company sold 3,116,012 shares of common stock under the agreement.
- Gross proceeds from these sales totaled approximately $5,680,924.
Price Impact
More from MAIA